Shire, Microsoft and EURODIS form rare diseases alliance
PharmaTimes | February 20, 2018
According to the parties, the “long road to diagnosis” is key issue that affects the health, longevity and well-being for rare disease patients and their families. The Global Commission to End the Diagnostic Odyssey for Children is a multi-disciplinary group of experts who will develop an “actionable roadmap” designed to shorten the multi-year diagnostic pathway.